1. Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib
   Yun-Ji Jeong et al, 2016, Oncology Letters CrossRef
2. HDAC inhibitor PAC-320 induces G2/M cell cycle arrest and apoptosis in human prostate cancer
   Zhixiong Dong et al, 2018, Oncotarget CrossRef
3. Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity
   Ryan Lillico et al, 2016, Future Medicinal Chemistry CrossRef
4. Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
   Cédric Poyet et al, 2014, BMC Clinical Pathology CrossRef
5. Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo
   Huaimin Liu et al, 2014, Tumor Biology CrossRef
6. New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma
   Ilknur Kozanoglu et al, 2013, Journal of Cancer Research and Clinical Oncology CrossRef
7. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
   Tahlita C.M. Zuiverloon et al, 2018, Bladder Cancer CrossRef
8. Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway
   Jin Xia et al, 2013, Tumor Biology CrossRef
9. Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme
   Filiz Senbabaoglu et al, 2016, Cancer Biology & Therapy CrossRef
10. Synthesis of xanthone derivatives based on α-mangostin and their biological evaluation for anti-cancer agents
    Xiang Fei et al, 2014, Bioorganic & Medicinal Chemistry Letters CrossRef